Long-term recovery after septic shock treatment
Part of Infections clinical trials.
This study checks on people who had septic shock and were in the ReActIF-ICE trial. It looks at how their immune system recovered over time after an experimental therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were in the ReActIF-ICE trial for septic shock.
- You passed the Day 2 re-check in that trial.
- You or your family agree to sign a permission form for this follow-up.
- You are willing to follow the study's rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting real-world data on ARTICE® treatment for adults in the ICU. It helps doctors understand how this treatment works in daily practice.
This trial tests an immune-cell treatment given outside the body to help people recover from septic shock, a life-threatening reaction to infection. It aims to improve survival and organ recovery in patients who are still very ill despite standard care.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
This study looks at how the immune system changes in people with septic shock. It aims to understand better how to monitor and potentially treat the immune suppression that can happen after a severe infection.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
Hear when a new Severe Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.